Global Veterinary Drug Premix 麻豆原创 Research Report 2023

Publication ID:

PB510239583

Publication Date:

October 11, 2023

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Agriculture [2]

Industry & Manufacturing [3]

Description:

Veterinary medicine premix is a solid or semi solid preparation made by mixing the active ingredients of veterinary medicine with suitable excipients in a certain proportion. It is a convenient form of veterinary medicine for use and management, commonly used in livestock and poultry farming.
The global Veterinary Drug Premix market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Drug Premix market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 146%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Drug Premix market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Bayer AG
Elanco
Zhejiang Esigma Biotechnology
Shandong Shengli Bioengineering
Jinhe Biotechnology
Shandong Luxi Animal Medicine Share
Zhengbang Group
Jiangsu Xinyu Pharmaceutical
Zhejiang Dayang Biotech Group
Zhengzhou Nongda Veterinary Medicine
China Tai Conti
Zhejiang Oulun Coating Technology
Pfizer Inc
Shandong Lukang Pharmaceutical
Zhejiang Kangmu Animal Health
Xinyu Pharmaceutical
INNER MONGOLIA Biok BIOLOGY
Segment by Type
Powder
Particles
Segment by Application
Plant Breeding
Self-Employed Person
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Veterinary Drug Premix report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers鈥� Outline
Chapter 8: Industry Chain, 麻豆原创 Channel and Customer Analysis
Chapter 9: 麻豆原创 Opportunities and Challenges
Chapter 10: 麻豆原创 Conclusions
Chapter 11: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Veterinary Drug Premix 麻豆原创 Overview
1.1 Product Definition
1.2 Veterinary Drug Premix Segment by Type
1.2.1 Global Veterinary Drug Premix 麻豆原创 Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Powder
1.2.3 Particles
1.3 Veterinary Drug Premix Segment by Application
1.3.1 Global Veterinary Drug Premix 麻豆原创 Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Plant Breeding
1.3.3 Self-Employed Person
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Veterinary Drug Premix Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Veterinary Drug Premix Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Veterinary Drug Premix Production Estimates and Forecasts (2018-2029)
1.4.4 Global Veterinary Drug Premix 麻豆原创 Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Veterinary Drug Premix Production 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Veterinary Drug Premix Production Value 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Key Players of Veterinary Drug Premix, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Veterinary Drug Premix 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Veterinary Drug Premix Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Veterinary Drug Premix, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Veterinary Drug Premix, Product Offered and Application
2.8 Global Key Manufacturers of Veterinary Drug Premix, Date of Enter into This Industry
2.9 Veterinary Drug Premix 麻豆原创 Competitive Situation and Trends
2.9.1 Veterinary Drug Premix 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Veterinary Drug Premix Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Veterinary Drug Premix Production by Region
3.1 Global Veterinary Drug Premix Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Veterinary Drug Premix Production Value by Region (2018-2029)
3.2.1 Global Veterinary Drug Premix Production Value 麻豆原创 Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Veterinary Drug Premix by Region (2024-2029)
3.3 Global Veterinary Drug Premix Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Veterinary Drug Premix Production by Region (2018-2029)
3.4.1 Global Veterinary Drug Premix Production 麻豆原创 Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Veterinary Drug Premix by Region (2024-2029)
3.5 Global Veterinary Drug Premix 麻豆原创 Price Analysis by Region (2018-2023)
3.6 Global Veterinary Drug Premix Production and Value, Year-over-Year Growth
3.6.1 North America Veterinary Drug Premix Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Veterinary Drug Premix Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Veterinary Drug Premix Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Veterinary Drug Premix Production Value Estimates and Forecasts (2018-2029)
4 Veterinary Drug Premix Consumption by Region
4.1 Global Veterinary Drug Premix Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Veterinary Drug Premix Consumption by Region (2018-2029)
4.2.1 Global Veterinary Drug Premix Consumption by Region (2018-2023)
4.2.2 Global Veterinary Drug Premix Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Veterinary Drug Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Veterinary Drug Premix Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Veterinary Drug Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Veterinary Drug Premix Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Veterinary Drug Premix Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Veterinary Drug Premix Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Veterinary Drug Premix Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Veterinary Drug Premix Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Veterinary Drug Premix Production by Type (2018-2029)
5.1.1 Global Veterinary Drug Premix Production by Type (2018-2023)
5.1.2 Global Veterinary Drug Premix Production by Type (2024-2029)
5.1.3 Global Veterinary Drug Premix Production 麻豆原创 Share by Type (2018-2029)
5.2 Global Veterinary Drug Premix Production Value by Type (2018-2029)
5.2.1 Global Veterinary Drug Premix Production Value by Type (2018-2023)
5.2.2 Global Veterinary Drug Premix Production Value by Type (2024-2029)
5.2.3 Global Veterinary Drug Premix Production Value 麻豆原创 Share by Type (2018-2029)
5.3 Global Veterinary Drug Premix Price by Type (2018-2029)
6 Segment by Application
6.1 Global Veterinary Drug Premix Production by Application (2018-2029)
6.1.1 Global Veterinary Drug Premix Production by Application (2018-2023)
6.1.2 Global Veterinary Drug Premix Production by Application (2024-2029)
6.1.3 Global Veterinary Drug Premix Production 麻豆原创 Share by Application (2018-2029)
6.2 Global Veterinary Drug Premix Production Value by Application (2018-2029)
6.2.1 Global Veterinary Drug Premix Production Value by Application (2018-2023)
6.2.2 Global Veterinary Drug Premix Production Value by Application (2024-2029)
6.2.3 Global Veterinary Drug Premix Production Value 麻豆原创 Share by Application (2018-2029)
6.3 Global Veterinary Drug Premix Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Bayer AG
7.1.1 Bayer AG Veterinary Drug Premix Corporation Information
7.1.2 Bayer AG Veterinary Drug Premix Product Portfolio
7.1.3 Bayer AG Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Bayer AG Main Business and 麻豆原创s Served
7.1.5 Bayer AG Recent Developments/Updates
7.2 Elanco
7.2.1 Elanco Veterinary Drug Premix Corporation Information
7.2.2 Elanco Veterinary Drug Premix Product Portfolio
7.2.3 Elanco Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Elanco Main Business and 麻豆原创s Served
7.2.5 Elanco Recent Developments/Updates
7.3 Zhejiang Esigma Biotechnology
7.3.1 Zhejiang Esigma Biotechnology Veterinary Drug Premix Corporation Information
7.3.2 Zhejiang Esigma Biotechnology Veterinary Drug Premix Product Portfolio
7.3.3 Zhejiang Esigma Biotechnology Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Zhejiang Esigma Biotechnology Main Business and 麻豆原创s Served
7.3.5 Zhejiang Esigma Biotechnology Recent Developments/Updates
7.4 Shandong Shengli Bioengineering
7.4.1 Shandong Shengli Bioengineering Veterinary Drug Premix Corporation Information
7.4.2 Shandong Shengli Bioengineering Veterinary Drug Premix Product Portfolio
7.4.3 Shandong Shengli Bioengineering Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Shandong Shengli Bioengineering Main Business and 麻豆原创s Served
7.4.5 Shandong Shengli Bioengineering Recent Developments/Updates
7.5 Jinhe Biotechnology
7.5.1 Jinhe Biotechnology Veterinary Drug Premix Corporation Information
7.5.2 Jinhe Biotechnology Veterinary Drug Premix Product Portfolio
7.5.3 Jinhe Biotechnology Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Jinhe Biotechnology Main Business and 麻豆原创s Served
7.5.5 Jinhe Biotechnology Recent Developments/Updates
7.6 Shandong Luxi Animal Medicine Share
7.6.1 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Corporation Information
7.6.2 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Product Portfolio
7.6.3 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Shandong Luxi Animal Medicine Share Main Business and 麻豆原创s Served
7.6.5 Shandong Luxi Animal Medicine Share Recent Developments/Updates
7.7 Zhengbang Group
7.7.1 Zhengbang Group Veterinary Drug Premix Corporation Information
7.7.2 Zhengbang Group Veterinary Drug Premix Product Portfolio
7.7.3 Zhengbang Group Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Zhengbang Group Main Business and 麻豆原创s Served
7.7.5 Zhengbang Group Recent Developments/Updates
7.8 Jiangsu Xinyu Pharmaceutical
7.8.1 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Corporation Information
7.8.2 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolio
7.8.3 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Jiangsu Xinyu Pharmaceutical Main Business and 麻豆原创s Served
7.7.5 Jiangsu Xinyu Pharmaceutical Recent Developments/Updates
7.9 Zhejiang Dayang Biotech Group
7.9.1 Zhejiang Dayang Biotech Group Veterinary Drug Premix Corporation Information
7.9.2 Zhejiang Dayang Biotech Group Veterinary Drug Premix Product Portfolio
7.9.3 Zhejiang Dayang Biotech Group Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhejiang Dayang Biotech Group Main Business and 麻豆原创s Served
7.9.5 Zhejiang Dayang Biotech Group Recent Developments/Updates
7.10 Zhengzhou Nongda Veterinary Medicine
7.10.1 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Corporation Information
7.10.2 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Product Portfolio
7.10.3 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Zhengzhou Nongda Veterinary Medicine Main Business and 麻豆原创s Served
7.10.5 Zhengzhou Nongda Veterinary Medicine Recent Developments/Updates
7.11 China Tai Conti
7.11.1 China Tai Conti Veterinary Drug Premix Corporation Information
7.11.2 China Tai Conti Veterinary Drug Premix Product Portfolio
7.11.3 China Tai Conti Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.11.4 China Tai Conti Main Business and 麻豆原创s Served
7.11.5 China Tai Conti Recent Developments/Updates
7.12 Zhejiang Oulun Coating Technology
7.12.1 Zhejiang Oulun Coating Technology Veterinary Drug Premix Corporation Information
7.12.2 Zhejiang Oulun Coating Technology Veterinary Drug Premix Product Portfolio
7.12.3 Zhejiang Oulun Coating Technology Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Zhejiang Oulun Coating Technology Main Business and 麻豆原创s Served
7.12.5 Zhejiang Oulun Coating Technology Recent Developments/Updates
7.13 Pfizer Inc
7.13.1 Pfizer Inc Veterinary Drug Premix Corporation Information
7.13.2 Pfizer Inc Veterinary Drug Premix Product Portfolio
7.13.3 Pfizer Inc Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Pfizer Inc Main Business and 麻豆原创s Served
7.13.5 Pfizer Inc Recent Developments/Updates
7.14 Shandong Lukang Pharmaceutical
7.14.1 Shandong Lukang Pharmaceutical Veterinary Drug Premix Corporation Information
7.14.2 Shandong Lukang Pharmaceutical Veterinary Drug Premix Product Portfolio
7.14.3 Shandong Lukang Pharmaceutical Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Shandong Lukang Pharmaceutical Main Business and 麻豆原创s Served
7.14.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
7.15 Zhejiang Kangmu Animal Health
7.15.1 Zhejiang Kangmu Animal Health Veterinary Drug Premix Corporation Information
7.15.2 Zhejiang Kangmu Animal Health Veterinary Drug Premix Product Portfolio
7.15.3 Zhejiang Kangmu Animal Health Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Zhejiang Kangmu Animal Health Main Business and 麻豆原创s Served
7.15.5 Zhejiang Kangmu Animal Health Recent Developments/Updates
7.16 Xinyu Pharmaceutical
7.16.1 Xinyu Pharmaceutical Veterinary Drug Premix Corporation Information
7.16.2 Xinyu Pharmaceutical Veterinary Drug Premix Product Portfolio
7.16.3 Xinyu Pharmaceutical Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.16.4 Xinyu Pharmaceutical Main Business and 麻豆原创s Served
7.16.5 Xinyu Pharmaceutical Recent Developments/Updates
7.17 INNER MONGOLIA Biok BIOLOGY
7.17.1 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Corporation Information
7.17.2 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Product Portfolio
7.17.3 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Production, Value, Price and Gross Margin (2018-2023)
7.17.4 INNER MONGOLIA Biok BIOLOGY Main Business and 麻豆原创s Served
7.17.5 INNER MONGOLIA Biok BIOLOGY Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Veterinary Drug Premix Industry Chain Analysis
8.2 Veterinary Drug Premix Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Veterinary Drug Premix Production Mode & Process
8.4 Veterinary Drug Premix Sales and 麻豆原创ing
8.4.1 Veterinary Drug Premix Sales Channels
8.4.2 Veterinary Drug Premix Distributors
8.5 Veterinary Drug Premix Customers
9 Veterinary Drug Premix 麻豆原创 Dynamics
9.1 Veterinary Drug Premix Industry Trends
9.2 Veterinary Drug Premix 麻豆原创 Drivers
9.3 Veterinary Drug Premix 麻豆原创 Challenges
9.4 Veterinary Drug Premix 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Bayer AG
Elanco
Zhejiang Esigma Biotechnology
Shandong Shengli Bioengineering
Jinhe Biotechnology
Shandong Luxi Animal Medicine Share
Zhengbang Group
Jiangsu Xinyu Pharmaceutical
Zhejiang Dayang Biotech Group
Zhengzhou Nongda Veterinary Medicine
China Tai Conti
Zhejiang Oulun Coating Technology
Pfizer Inc
Shandong Lukang Pharmaceutical
Zhejiang Kangmu Animal Health
Xinyu Pharmaceutical
INNER MONGOLIA Biok BIOLOGY

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.